MedTrace Logo

Early Identification of Warfarin Maintenance Dosage

NCT01178034 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2012-10-23

No results posted yet for this study

Summary

Initiation of warfarin therapy is problematic. The investigators goal was to evaluate if a new demographic/pharmacogenetic algorithm is better than a usual algorithm based on INR value at day five after four days of 5 mg/day warfarin. To this end patients with atrial fibrillation starting warfarin are randomized in two arms.

Conditions

Interventions

GENETIC

Calculate warfarin dose using demographic/genetic algorithm

Age, body weight and genetic to calculate warfarin dosage

Sponsors & Collaborators

  • University of Padova

    lead OTHER

Principal Investigators

  • Vittorio Pengo, M.D. · University of Padova

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01178034 on ClinicalTrials.gov